Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
about
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Myoinositol as a Biomarker in ...... Resonance Spectroscopy Study.
@ast
Myoinositol as a Biomarker in ...... Resonance Spectroscopy Study.
@en
type
label
Myoinositol as a Biomarker in ...... Resonance Spectroscopy Study.
@ast
Myoinositol as a Biomarker in ...... Resonance Spectroscopy Study.
@en
prefLabel
Myoinositol as a Biomarker in ...... Resonance Spectroscopy Study.
@ast
Myoinositol as a Biomarker in ...... Resonance Spectroscopy Study.
@en
P2093
P2860
P50
P1433
P1476
Myoinositol as a Biomarker in ...... c Resonance Spectroscopy Study
@en
P2093
Friedhelm Zanella
Joachim P Steinbach
Oliver Bähr
Ulrich Pilatus
P2860
P304
P356
10.1371/JOURNAL.PONE.0168113
P407
P577
2016-12-29T00:00:00Z